Industry
Training- workforce upskilling
The Recombinant Products Facility has a long-standing commitment to training UNSW researchers and students, a tradition that spans over 15 years. Throughout this period, we have developed high-quality training materials and resources. Our approach to training has yielded significant results, with many of our alumni securing positions in renowned companies and institutions.
Recognizing the recent surge in the bioprocessing field and the escalating demand for expertise in this area, the Recombinant Products Facility has taken steps to broaden our training initiatives. We now extend our training programs to industry professionals and individuals seeking to augment their bioprocessing skills. This expansion is our response to the industry's growing need for well-trained and skilled individuals, further strengthening our commitment to advancing the field.
Feel free to contact us for more details about this new initiative.
Request full service
RPF offers comprehensive processing services.
Our full-service capabilities encompass all aspects of protein and biologic production and purification, from expression testing and fermentation to mid-stream and downstream processing (purification), including characterisation and stability studies.
Our expert team is readily available for an initial consultation, during which we can assess your project's requirements and provide pricing information at no cost.
RPF is accredited, adheres to a quality management system, and conducts contract work in strict compliance with ISO 9001 standards. Feel free to contact us for further details.
Therapeutics Innovation Australia (TIA) and National Collaborative Research Infrastructure Strategy (NCRIS)
The Recombinant Products Facility is a TIA facility, meaning that government support is available to use our services for the development of biologics. TIA has developed the Pipeline Accelerator voucher scheme, with successful applicants able to receive up to $50,000 in matching funds to develop therapeutic projects using RPF capabilities. See the Pipeline Accelerator Scheme link below for more information.
Therapeutics Innovation Australia (TIA)
National Collaborative Research Infrastructure Strategy (NCRIS)
Investment NSW
The Recombinant Products Facility operates as a Public Funded Research Organisation within the TechVoucher Scheme. This initiative aims to enhance productivity and foster business expansion by transforming knowledge and inventions into innovative products and services. Investment NSW has allocated funds for this scheme, enabling qualified participants to access up to $50,000 in matching funds. For further details, please refer to the provided link for the TechVoucher Scheme.